INDICATION OF HPV VACCINE IN THE TREATMENT OF A CHILD WITH RECURRENT LARYNGEAL PAPILLOMATOSIS

Health and Society Pub Date : 2024-01-24 DOI:10.51249/hs.v4i01.1840

Bruna Letícia Ferreira, Luanna Maurícia Souza, Romana Aparecida Alves Barbosa, Claudia Cristina Teixeira, Matheus De Freitas Villela, Cinara Coutinho Ferreira, Greicy Kelly Duarte de Oliveira Lopes, Bryan Rocha de Oliveira, Leandro Felipe Antunes da Silva, Sarah Gabrielle Rodrigues Peixoto, Hanna Emanuelle Rocha dos Santos, Sabrina Gonçalves Silva Pereira, Ana Clara Dias Mendes, Karla Geovania Souza, Ivani Ferreira da Silva Albuquerque, Kelly Tatiane Pereira de Jesus Ribeiro, Sabrina Gonçalves de Souza

{"title":"INDICATION OF HPV VACCINE IN THE TREATMENT OF A CHILD WITH RECURRENT LARYNGEAL PAPILLOMATOSIS","authors":"Bruna Letícia Ferreira, Luanna Maurícia Souza, Romana Aparecida Alves Barbosa, Claudia Cristina Teixeira, Matheus De Freitas Villela, Cinara Coutinho Ferreira, Greicy Kelly Duarte de Oliveira Lopes, Bryan Rocha de Oliveira, Leandro Felipe Antunes da Silva, Sarah Gabrielle Rodrigues Peixoto, Hanna Emanuelle Rocha dos Santos, Sabrina Gonçalves Silva Pereira, Ana Clara Dias Mendes, Karla Geovania Souza, Ivani Ferreira da Silva Albuquerque, Kelly Tatiane Pereira de Jesus Ribeiro, Sabrina Gonçalves de Souza","doi":"10.51249/hs.v4i01.1840","DOIUrl":null,"url":null,"abstract":"Laryngeal papillomatosis or Recurrent Respiratory Papillomatosis (PRR) is the main cause of benign laryngeal neoplasia characterized by the proliferation of epithelial lesions with the presence of warts, called papillomas. These are often multiple and recurrent, being caused by The Human Papilloma Virus (HPV). Currently, there are no surgical or curative medical treatments for the disease. The literature indicates several options, including the quadrivalent HPV vaccine. In this sense, this study sought to report a clinical case of a child with recurrent respiratory papillomatosis, with emphasis on the quadrivalent HPV vaccine used as adjuvant therapy. In this case study, it was evidenced that immunization can be used as adjuvant therapy.","PeriodicalId":507713,"journal":{"name":"Health and Society","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health and Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51249/hs.v4i01.1840","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Laryngeal papillomatosis or Recurrent Respiratory Papillomatosis (PRR) is the main cause of benign laryngeal neoplasia characterized by the proliferation of epithelial lesions with the presence of warts, called papillomas. These are often multiple and recurrent, being caused by The Human Papilloma Virus (HPV). Currently, there are no surgical or curative medical treatments for the disease. The literature indicates several options, including the quadrivalent HPV vaccine. In this sense, this study sought to report a clinical case of a child with recurrent respiratory papillomatosis, with emphasis on the quadrivalent HPV vaccine used as adjuvant therapy. In this case study, it was evidenced that immunization can be used as adjuvant therapy.

查看原文本刊更多论文

治疗复发性喉乳头状瘤病儿童的 HPV 疫苗适应症

喉乳头状瘤病或复发性呼吸道乳头状瘤病（PRR）是喉良性肿瘤的主要病因，其特点是上皮病变增生并伴有疣，即乳头状瘤。这些疣通常由人类乳头瘤病毒（HPV）引起，具有多发性和复发性。目前，这种疾病还没有手术或药物治疗方法。文献指出了几种选择，包括四价人乳头瘤病毒疫苗。因此，本研究试图报告一例复发性呼吸道乳头状瘤病患儿的临床病例，重点是将四价人乳头状瘤病毒疫苗用作辅助治疗。本病例研究证明，免疫接种可用作辅助治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Health and Society

自引率

0.00%

发文量